2 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Selected peptides as drug candidates directed to pain and neurodegeneration (PEP2BRAIN)
Date du début: 1 mars 2009, Date de fin: 28 févr. 2013,
"BLV200703/4 is a small molecule discovered jointly by groups from the University of Lisbon (Portugal) and Girona (Spain) that proved its efficacy in analgesia from behavioural tests in rats. The same molecule was tested in a platform that screens potential pharmacological molecules/compounds for neurodegenerative diseases with positive results. The platform is owned by Bioalvo, SA (Portugal). The ...
Voir le projet
5
Participants partenaires
TERMINÉ
Novel anti-inflammatory compounds for autoimmune diseases (KINACEPT)
Date du début: 1 déc. 2008, Date de fin: 30 nov. 2010,
"The consortium has a lead series of p38 inhibitors with unusual anti-inflammatory properties. The drug leads were originally elaborated as a potential therapy for inflammatory bowel disease, however, the potency of the compounds and their general anti-inflammatory mode of action has raised the possibility of studying their utility in other diseases including rheumatoid arthritis. In addition ...
Voir le projet